🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to assess the activity of XRP9881 in ...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2006-07
Trial ID
NCT00386685
Treatments Being Tested
The purpose of this study is to compare the efficacy and the safety Larotax...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2006-12
Trial ID
NCT00417209
Treatments Being Tested
The purpose of this study is to evaluate the anti-tumor activity of the com...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2006-10
Trial ID
NCT00387907
Treatments Being Tested
This is a randomized, open-label, multi-center study comparing the efficacy...
Status
Completed
Location
Sanofi-Aventis Investigational Site Number 840068
Start Date
2008-02
Trial ID
NCT00625664
Treatments Being Tested
The purpose of this clinical trial is to determine if the investigational d...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2004-08
Trial ID
NCT00087958
Treatments Being Tested
The purpose of this clinical trial is to determine if RPR109881 is a better...
Status
Completed
Location
Multiple Locations
Start Date
2004-04
Trial ID
NCT00081796
Treatments Being Tested
The primary objective of this study is to assess the pathological Complete ...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2007-06
Trial ID
NCT00485979
Treatments Being Tested
The goal of this phase I-II clinical research study is to find the highest ...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2006-08
Trial ID
NCT00327743
Treatments Being Tested